[Table/Fig-2]:
Age (years) | Type of statins | Study group | OR* | 95% CI† for OR |
p | |||
---|---|---|---|---|---|---|---|---|
case | Control | |||||||
n | % | n | % | |||||
<50 | Atorvastatin | |||||||
+ | 12 | 35.3 | 14 | 34.1 | 1.05 | 0.36-3.04 | 0.918 | |
- | 22 | 64.7 | 27 | 65.9 | ||||
Simvastatin | ||||||||
+ | 2 | 8.3 | 6 | 18.2 | 0.41 | 0.05-2.62 | 0.295 | |
- | 22 | 91.7 | 27 | 81.8 | ||||
All statin user | ||||||||
+ | 14 | 38.9 | 20 | 46.6 | 0.86 | 0.32-2.28 | 0.738 | |
- | 22 | 61.1 | 27 | 57.4 | ||||
50-59 | Atorvastatin | |||||||
+ | 12 | 21.8 | 17 | 37.0 | 0.48 | 0.18-1.24 | 0.096 | |
- | 43 | 78.2 | 29 | 63.0 | ||||
Simvastatin | ||||||||
+ | 6 | 12.2 | 6 | 17.1 | 0.67 | 0.17-2.67 | 0.530 | |
- | 43 | 87.8 | 29 | 82.9 | ||||
All statin user | ||||||||
+ | 18 | 29.5 | 23 | 44.4 | 0.530 | 0.230-1.23 | 0.106 | |
- | 43 | 70.5 | 29 | 55.8 | ||||
≥60 | Atorvastatin | |||||||
+ | 8 | 18.2 | 17 | 43.6 | 0.29 | 0.09-0.86 | 0.012 | |
- | 36 | 81.8 | 22 | 56.4 | ||||
Simvastatin | ||||||||
+ | 3 | 7.7 | 6 | 21.4 | 0.31 | 0.05-1.59 | 0.107 | |
- | 36 | 92.3 | 22 | 78.6 | ||||
All statin user | ||||||||
+ | 11 | 23.4 | 23 | 51.1 | 0.29 | 0.11-0.78 | 0.006 | |
- | 36 | 76.6 | 22 | 48.9 |
*OR: Odds Risk †CI: Confidence Interval